ACHL
Achilles Therapeutics PLC ADR
NASDAQ: ACHL · HEALTHCARE · BIOTECHNOLOGY
$1.48
+0.00% today
Updated 2026-04-29
Market cap
$63.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.66
Dividend yield
—
52W range
$0 – $0
Volume
1.2M
Achilles Therapeutics PLC ADR (ACHL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-41.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-14.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.8%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-3.8%
2024-11-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2024-11-11 | $-0.48 | +0.0% | $1.05 | $1.01 | -3.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-09-30 | $-0.48 | $-0.48 | +0.0% | — | — |
| 2024-06-30 | $-0.41 | $-0.41 | +0.0% | — | — |
| 2024-03-31 | $-0.46 | $-0.30 | +34.8% | — | — |
| 2023-12-31 | $-0.14 | $-0.46 | -228.6% | — | — |
| 2023-09-30 | $-0.40 | $-0.42 | -5.0% | — | — |
| 2023-06-30 | $-0.42 | $-0.42 | +0.0% | — | — |
| 2023-03-31 | $-0.40 | $-0.44 | -10.0% | — | — |
| 2022-12-31 | $-0.41 | $-0.61 | -48.8% | — | — |
| 2022-09-30 | $-0.55 | $-0.32 | +41.8% | — | — |
| 2022-06-30 | $-0.56 | $-0.44 | +21.4% | — | — |
| 2022-03-31 | $-0.50 | $-0.45 | +10.0% | — | — |
| 2021-12-31 | $-0.41 | $-0.45 | -9.8% | — | — |
Frequently asked questions
Has Achilles Therapeutics PLC ADR beaten earnings estimates?
Achilles Therapeutics PLC ADR has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -41.3% over the last 4 quarters.
How does ACHL stock react to earnings?
ACHL stock has moved an average of -3.8% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.